Form 4 for AORT ARTIVION, INC.
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-13 · accession 0000784199-25-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-16 | 2025-06-13 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $28.44 | -26.1K | 79.2K | -25% | -$743.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-13 | S | D | 8,747 | $28.46 | 96,585 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025. (F2) Reflects weighted average price for Performance Stock Units. Range of prices were between $28.175 to $28.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-06-13 | S | D | 1,253 | $28.47 | 95,332 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025. (F3) Reflects weighted average price for Employee Stock Purchase Plan. Range of prices were between $28.18 to $28.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-06-13 | S | D | 14,306 | $28.42 | 81,026 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025. (F4) Reflects weighted average price for Performance Stock Units. Range of prices were between $28.17 to $28.675. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-06-13 | S | D | 1,826 | $28.43 | 79,200 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025. (F3) Reflects weighted average price for Employee Stock Purchase Plan. Range of prices were between $28.18 to $28.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |